142 related articles for article (PubMed ID: 10385186)
1. HL-91-technetium-99m: a new marker of viability in ischemic myocardium.
Okada RD; Johnson G; Nguyen KN; Carlson LR; Beju D
J Nucl Cardiol; 1999; 6(3):306-15. PubMed ID: 10385186
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-HL91. Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent.
Okada RD; Johnson G; Nguyen KN; Edwards B; Archer CM; Kelly JD
Circulation; 1997 Apr; 95(7):1892-9. PubMed ID: 9107178
[TBL] [Abstract][Full Text] [Related]
3. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.
Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Pak KY; Okada RD
J Nucl Cardiol; 2003; 10(2):168-76. PubMed ID: 12673182
[TBL] [Abstract][Full Text] [Related]
4. Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium.
Johnson G; Allton IL; Nguyen KN; Lauinger JM; Beju D; Pasqualini R; Duatti A; Okada RD
J Nucl Cardiol; 1996; 3(1):42-54. PubMed ID: 8799227
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model.
Okada DR; Liu Z; Johnson G; Beju D; Khaw BA; Okada RD
Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1909-17. PubMed ID: 20652807
[TBL] [Abstract][Full Text] [Related]
6. Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99m sestamibi kinetics.
Liu Z; Johnson G; Beju D; Okada RD
J Nucl Cardiol; 2001; 8(6):677-86. PubMed ID: 11725264
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
Liu M; Ma Z; Guo X; Zhu J; Su J
Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
[TBL] [Abstract][Full Text] [Related]
8. Monocationic radiotracer kinetics and myocardial infarct size: a perfused rat heart study.
Okada DR; Liu Z; Beju D; Okada RD; Johnson G
Ann Nucl Med; 2008 Aug; 22(7):617-27. PubMed ID: 18756365
[TBL] [Abstract][Full Text] [Related]
9. Effects of no flow and reperfusion on technetium-99m-Q12 kinetics.
Okada RD; Nguyen KN; Lauinger M; Allton IL; Spreitzer K; Beju D; Johnson G
J Nucl Med; 1995 Nov; 36(11):2103-9. PubMed ID: 7472606
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model.
Liu Z; Okada DR; Johnson G; Hocherman SD; Beju D; Okada RD
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):570-8. PubMed ID: 17952434
[TBL] [Abstract][Full Text] [Related]
11. Assessment of reperfused myocardium using a new ischaemia-avid imaging agent, technetium-99m HL91: comparison with myocardial glucose uptake.
Fukuchi K; Kusuoka H; Yutani K; Hasegawa S; Nishimura T
Eur J Nucl Med; 1998 Apr; 25(4):361-6. PubMed ID: 9553165
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of a putative hypoxic tracer, 99mTc-HL91, in normoxic, hypoxic, ischemic, and stunned myocardium.
Imahashi K; Morishita K; Kusuoka H; Yamamichi Y; Hasegawa S; Hashimoto K; Shirakami Y; Kato-Azuma M; Nishimura T
J Nucl Med; 2000 Jun; 41(6):1102-7. PubMed ID: 10855642
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of technetium-99m-teboroxime in reperfused nonviable myocardium.
Okada RD; Glover DK; Moffett JD; Beju D; Johnson G
J Nucl Med; 1997 Feb; 38(2):274-9. PubMed ID: 9025755
[TBL] [Abstract][Full Text] [Related]
14. Tc-99m-HL91 imaging in the early detection of neuronal injury in a neonatal rat model of hypoxic ischemia.
Lee BF; Wang LW; Lin SH; Jhuo TJ; Chiu NT; Huang CC; Hsia CC; Shen LH
Crit Care Med; 2012 Jun; 40(6):1930-8. PubMed ID: 22610194
[TBL] [Abstract][Full Text] [Related]
15. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.
Beanlands RS; DeKemp RA; Harmsen E; Veinot JP; Hartman NG; Ruddy TD
J Am Coll Cardiol; 1996 Aug; 28(2):487-94. PubMed ID: 8800130
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia imaging of patients with acute myocardial infarction by using dual isotopes of 201Tl and 99mTc-HL91.
Yang XJ; He YM; Wu YW; Zhang B; Hui J; Jiang TB; Song JP; Liu ZH; Jiang WP
Nucl Med Commun; 2008 Mar; 29(3):230-8. PubMed ID: 18349793
[TBL] [Abstract][Full Text] [Related]
17. Influence of calcium channel inhibitors on the myocardial uptake and retention of technetium 99m N-NOET, a new myocardial perfusion imaging agent: a study on isolated perfused rat hearts.
Riou L; Ghezzi C; Pasqualini R; Fagret D
J Nucl Cardiol; 2000; 7(4):365-72. PubMed ID: 10958279
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics.
Beanlands RS; Ruddy TD; Bielawski L; Johansen H
J Nucl Cardiol; 1997; 4(4):274-82. PubMed ID: 9278873
[TBL] [Abstract][Full Text] [Related]
19. Detection of ischemic myocardium with a new hypoxic tissue targeting tracer 99Tc(m)-HL91.
Lü J; Liu G; Fang Y; Wu H
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):281-3, 291. PubMed ID: 16961269
[TBL] [Abstract][Full Text] [Related]
20. Verapamil does not inhibit 99mTcN-NOET uptake in situ in normal or ischemic canine myocardium.
Riou LM; Ghezzi C; Vanzetto G; Broisat A; Mathieu JP; Bontron R; Pasqualini R; Fagret D
J Nucl Med; 2003 Jun; 44(6):981-7. PubMed ID: 12791829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
